Financial statements Apteka Eskulap Spj. D. I R. Gargol W Likwidacji
Balance sheet data of APTEKA ESKULAP SPJ. D. I R. GARGOL W LIKWIDACJI
Year
|
2022
|
2023
|
---|---|---|
Total assets | 895 537,74 | 499 879,40 |
A. Fixed assets | 16 046,80 | 12 608,20 |
B. Current assets | 879 490,94 | 487 271,20 |
C. Share capital contributions (basic funds) | - | - |
D. Own shares (stocks) | - | - |
Total liabilities | 895 537,74 | 499 879,40 |
A. Equity | -170 093,23 | -160 870,89 |
B. Liabilities and provisions for liabilities | 1 065 630,97 | 660 750,29 |
I. Long-term liabilities | - | - |
II. Short-term liabilities | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.